News

Public · Published

RKLB Stock Draws Wall Street's Attention – Cantor Sees Attractive Entry Point Ahead Of These Two Key Events

Rocket Lab reported third-quarter revenue of $267.83 million, up 73% and above the $257.18 million consensus estimate, but its $0.12-per-share loss was larger than expected. Cantor Fitzgerald cut its price target to $111 from $122 while keeping an Overweight rating, and Rocket Lab forecast fourth-quarter revenue of $270 million to $290 million.

Published:

Updated:

What happened

Rocket Lab reported third-quarter revenue of $267.83 million, up 73% and above the $257.18 million consensus estimate, but its $0.12-per-share loss was larger than expected. Cantor Fitzgerald cut its price target to $111 from $122 while keeping an Overweight rating, and Rocket Lab forecast fourth-quarter revenue of $270 million to $290 million.

Confirmed

Global impact / market context

Revenue growth and a strong forecast could support expectations that Rocket Lab can expand sales, while the larger-than-expected loss shows that growth has not yet translated into better results per share. Neutron commercialization and the proposed Iridium acquisition closing are potential catalysts, but execution and timing matter.

Analyst inference

Analyst views were mixed but remained positive: Cantor kept an Overweight rating despite lowering its target, and Clear Street raised its target and retained a Buy rating. Piper Sandler emphasized Neutron’s launch timeline, underscoring that delivery timing may shape expectations alongside financial results.

Confirmed

What to watch

  1. Compare fourth-quarter revenue with Rocket Lab’s $270 million to $290 million forecast; falling short could weaken sales expectations, while meeting it would support the company’s stated outlook. Analyst inference
  2. Watch for updates on Neutron commercialization and its launch timeline, since delays could postpone expected commercial activity and affect how investors assess Rocket Lab’s growth prospects. Analyst inference
  3. Track whether the Iridium acquisition closes, as Cantor identified its closing as an event ahead and completion could change Rocket Lab’s business scope. Analyst inference

Evidence